The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr13
start 91351065
end 91351135
ID MI0000076
miRNA_name hsa-miR-20a
methods qRT-PCR,microarray,etc.
regulated up
Function Description Results: Based on the results of microRNA profiling, seven miRNAs were selected for further validation. In the HR+/HER2- cohort (n = 51) dynamics of three miRNAs, including miR-222, miR-20a, and miR-451, were associated with chemo-sensitivity. Importantly, across all the three subtypes we consistently identified chemo-induced decrease in plasma miR-34a in the insensitive patients. Finally, baseline miR-222 overexpression (OR = 6.422, P = 0.049), C2 miR-20a up-regulation (OR = 0.144, P = 0.021) and C2 miR-451 down-regulation (OR = 8.213, P = 0.012) were predictive markers of response to NCT in HR+/HER2- breast cancer.Conclusions: We described that dynamics of circulating miRNAs might help predict clinical response to NCT in breast cancer.
PMID 30099860
year 2018
Title Dynamics of Circulating microRNAs as a Novel Indicator of Clinical Response to Neoadjuvant Chemotherapy in Breast Cancer
drug X
circulating V
survival X

CopyRight © University of Miami, USA; Harbin Medical University, China